Benjamin Hickey - Jan 9, 2023 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
EVP, Chief Commercial Officer
Signature
/s/ Reena R. Desai, Attorney-in-Fact
Stock symbol
MRTX
Transactions as of
Jan 9, 2023
Transactions value $
-$94,733
Form type
4
Date filed
1/10/2023, 04:00 PM
Previous filing
Dec 21, 2022
Next filing
Jan 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale -$94.7K -2.09K -4.1% $45.37 48.8K Jan 9, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 6, 2020.